No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
97 |
4. Check minimum number of eventsNone |
97 |
5. Include endpointsNone |
97 |
6. Filter based on genotype QC (FinnGen only) |
93 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF6v3
Similar endpoints
↥List of similar endpoints to
Congenital malformation of biliary tract
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of gallbladder, bile ducts and liver
- Other congenital malformations of the digestive system
- Other congenital malformations of the digestive system
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 598 | 347 | 248 |
| Only index persons | 436 | 264 | 172 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 24.75 | 29.19 | 17.94 |
| Only index persons | 42.30 | 43.81 | 39.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 93 | 58 | 35 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 14.10 | 14.91 | 12.76 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 97
- Matched controls
- 970
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
+∞
50.5
44
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
94.2
40.6
43
8
K83.0
ICD-10 Finland
Cholangitis
153.4
38.0
38
*
A05AA02
ATC
ursodeoxycholic acid; oral
97.9
35.1
37
6
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
112.5
34.7
36
5
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
67.9
34.0
38
9
Q44.29
ICD-10 Finland
Atresia of bile ducts
+∞
33.2
30
*
JKD50
NOMESCO Finland
Hepatoportoenterostomy
+∞
32.1
29
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
46.9
31.6
38
13
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
14.2
30.3
33
34
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
15.6
30.0
30
27
Z94.4
ICD-10 Finland
Liver transplant status
194.0
28.3
28
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
8.5
25.7
57
139
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
28.3
24.9
34
18
127
Kela drug reimbursment
Transplant complication
38.7
24.1
30
11
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.9
23.8
56
143
TPH04
NOMESCO Finland
Cathetrisation of vein
7.7
22.3
46
102
Q44.20
ICD-10 Finland
Atresia of intrahepatic bile ducts
+∞
21.7
20
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.7
20.7
39
78
Q44.4
ICD-10 Finland
Choledochal cyst
+∞
20.5
19
*
L04AD02
ATC
tacrolimus; systemic
41.3
20.5
25
8
H02AB04
ATC
methylprednisolone; systemic
8.8
20.2
31
49
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
10.4
20.2
26
33
A11CC03
ATC
alfacalcidol; systemic
44.8
20.0
24
7
JN3AD
NOMESCO Finland
Abdominal CT examination
10.1
19.7
26
34
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
124.5
19.4
20
*
JAH00
NOMESCO Finland
Laparotomy
31.3
18.4
24
10
L04AX01
ATC
azathioprine; systemic
19.1
18.2
28
20
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
218.2
18.2
18
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
62.1
17.8
20
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
19.2
17.7
27
19
WX402
NOMESCO Finland
General anaesthesia
5.9
17.2
59
202
TPH07
NOMESCO Finland
Cathetrisation of artery
6.5
17.1
38
88
WX302
NOMESCO Finland
Thoracal epidural anesthesy
26.9
17.0
23
11
K83.1
ICD-10 Finland
Obstruction of bile duct
58.3
16.7
19
*
H02AB09
ATC
hydrocortisone; systemic
9.1
16.5
23
32
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
72.7
16.4
18
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
102.0
16.1
17
*
Z94.0
ICD-10 Finland
Kidney transplant status
46.6
16.1
19
5
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
7.4
15.6
27
48
RD210, ,
NOMESCO Finland
7.8
15.0
24
39
ZXE10
NOMESCO Finland
More than one and less than three hours
5.3
14.9
62
242
Z2446
NOMESCO Finland
Social worker
5.6
14.8
39
104
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.8
14.5
23
37
L04AD01
ATC
ciclosporin; systemic
22.5
14.1
20
11
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
87.5
14.0
15
*
Q44.1
ICD-10 Finland
Other congenital malformations of gallbladder
+∞
13.9
13
*
ZXD05
NOMESCO Finland
Urgent procedure
4.9
13.4
47
157
ZXD10
NOMESCO Finland
Scheduled procedure
5.0
13.3
65
280
J01MA02
ATC
ciprofloxacin; systemic
4.9
13.3
43
135
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
37.8
13.0
16
5
JJC00
NOMESCO Finland
Allogenic transplantation of liver
80.8
13.0
14
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.8
12.9
42
132
Q44.0
ICD-10 Finland
Agenesis, aplasia and hypoplasia of gallbladder
+∞
12.8
12
*
Q44.3
ICD-10 Finland
Congenital stenosis and stricture of bile ducts
+∞
12.8
12
*
C03DA01
ATC
spironolactone; oral
6.6
12.8
24
46
WX408
NOMESCO Finland
General anesthesy, balanced
4.6
12.8
55
214
R4110
NOMESCO Finland
Physiotherapy
4.6
12.7
54
208
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
13.8
12.3
21
19
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.2
12.1
32
84
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
11.2
12.1
23
26
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.4
11.7
49
184
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
+∞
11.7
11
*
Z3226
NOMESCO Finland
Physiotherapist
4.3
11.5
46
167
ZXE00
NOMESCO Finland
One hour or less
4.3
11.1
63
292
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
25.0
11.1
15
7
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
67.7
10.9
12
*
JJC10
NOMESCO Finland
Allogenic partial transplantation of liver
+∞
10.6
10
*
K00.81
ICD-10 Finland
Color changes in the teeth caused by biliary anomalies
+∞
10.6
10
*
BE00A, ,
NOMESCO Finland
+∞
10.6
10
*
UJK02
NOMESCO Finland
ERCP
26.9
10.6
14
6
R4190
NOMESCO Finland
Nutritional therapy
4.4
10.5
36
115
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.8
10.4
22
47
XF602
NOMESCO Finland
Bloodpressure monitoring
19.4
10.3
15
9
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
9.8
10.0
20
25
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
5.1
9.6
24
59
JJA20
NOMESCO Finland
Open biopsy of liver
+∞
9.5
9
*
R50.9
ICD-10 Finland
Fever, unspecified
3.8
9.4
41
155
ZXD20
NOMESCO Finland
Day surgery
5.2
9.2
22
52
L04AA06
ATC
mycophenolic acid; systemic
16.1
9.0
14
10
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.1
8.7
30
95
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
22.5
8.7
12
6
R18
ICD-10 Finland
Ascites
+∞
8.4
8
*
JK3AN
NOMESCO Finland
Biliary tract isotope imaging
+∞
8.4
8
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
13.4
8.4
14
12
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
19.3
8.3
12
7
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.9
8.1
18
27
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
8.3
7.9
17
24
5AB14, ,
NOMESCO Finland
27.5
7.7
10
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.8
7.7
29
97
WX882
NOMESCO Finland
High dependency care
4.0
7.6
26
81
JJ5AT, ,
NOMESCO Finland
86.4
7.5
8
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
7.4
7
*
Q44.5
ICD-10 Finland
Other congenital malformations of bile ducts
+∞
7.4
7
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
22.0
7.3
10
5
V03AG01
ATC
sodium cellulose phosphate; systemic
32.7
7.3
9
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.4
7.1
14
17
L04AA01
ATC
[U] ciclosporin
43.2
6.9
8
*
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
43.2
6.9
8
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
11.2
6.7
12
12
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
6.7
52
268
K03.66
ICD-10 Finland
Tooth plaque
3.5
6.6
28
101
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
15.7
6.6
10
7
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
74.5
6.5
7
*
602
Kela drug reimbursment
Children's severe malnutrition
6.6
6.5
16
28
Z2221
NOMESCO Finland
Medical doctor
3.0
6.3
40
183
K83.5
ICD-10 Finland
Biliary cyst
+∞
6.3
6
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
6.3
6
*
Z3231
NOMESCO Finland
Registered nurse
2.9
6.1
51
271
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
44
11
72.38
76.03
4.5
6.9
26.60
36.43
u/ml
0.09
44
11
79
114
32.96
63.08
36.8
5.7
11.48
5.92
umol/l
1.94
79
95
40
15
44.68
61.27
9.4
2.5
20.98
29.27
umol/l
1.92
40
15
42
22
32.91
56.91
17.2
3.4
95.10
91.68
%
0.23
42
22
48
67
13.20
36.35
15.5
6.1
179.96
171.06
%
0.40
48
67
49
87
10.36
30.08
17.7
10.0
107.35
88.85
%
3.93
49
87
80
295
10.77
23.38
27.6
8.3
35.43
36.28
g/l
0.65
80
289
28
9
42.88
23.05
3.5
1.8
—
—
—
0
0
62
185
7.52
22.20
6.9
3.5
—
—
—
0
0
31
46
9.43
21.40
3.8
4.2
3.59
11.32
ug/l
0.84
23
36
31
46
9.43
21.40
3.0
2.3
—
—
—
0
0
31
47
9.22
21.00
3.0
2.3
249.17
120.11
u/ml
1.64
23
18
61
187
7.09
20.97
5.7
3.8
0.50
0.60
e6/l
0.27
48
120
27
11
33.34
20.95
6.1
3.8
—
—
—
0
0
60
182
7.02
20.83
5.7
4.2
2.32
1.62
e6/l
0.32
49
117
57
165
6.95
20.79
13.9
4.5
1.88
2.11
mg/l
0.07
49
133
35
66
7.73
19.49
6.5
3.4
59.14
29.46
u/l
1.10
29
56
45
113
6.56
18.79
6.7
3.0
2.64
2.50
g/l
0.80
45
106
29
48
8.19
18.05
3.9
1.9
—
—
—
0
0
46
134
5.63
15.93
6.8
2.9
11.83
12.93
umol/l
0.40
46
125
67
273
5.70
15.38
14.5
11.5
1.16
1.31
inr
—
10
77
55
192
5.31
15.23
24.5
9.1
23.85
23.28
mmol/l
1.22
55
192
57
205
5.32
15.21
33.8
10.2
1.28
1.34
mmol/l
0.97
57
200
71
313
5.73
14.54
7.2
3.2
—
—
—
0
0
57
211
5.13
14.52
26.4
9.6
0.78
1.08
mmol/l
0.37
57
159
66
277
5.33
14.29
9.3
4.4
0.05
0.33
e6/l
2.29
59
212
35
93
5.32
13.17
18.1
12.9
106.17
104.37
mmol/l
1.15
35
93
68
314
4.90
12.48
9.8
4.6
—
—
—
0
0
81
441
6.07
11.72
44.5
13.6
1.22
1.23
mmol/l
1.08
81
418
56
233
4.32
11.60
37.9
13.4
24.48
24.74
mmol/l
0.30
56
233
18
24
8.94
8.64
2.8
1.8
—
—
—
0
0
20
48
4.99
8.19
3.8
3.3
72.40
68.95
ml/min/173m2
—
5
19
30
100
3.90
8.07
2.7
2.2
—
—
—
0
0
66
364
3.54
8.01
6.1
4.0
0.00
0.00
estimate
—
8
56
30
101
3.85
7.94
2.3
2.0
—
—
—
0
0
34
127
3.58
7.70
2.6
2.1
—
—
—
0
0
65
361
3.43
7.68
9.6
5.6
0.00
0.00
estimate
—
8
57
65
362
3.41
7.62
6.2
4.0
0.00
0.00
estimate
—
7
59
20
51
4.68
7.60
18.3
17.4
0.78
0.69
%
0.25
20
51
20
51
4.68
7.60
18.5
17.4
1.45
1.18
%
0.52
20
51
18
42
5.03
7.59
20.6
19.9
24.39
23.93
mmol/l
0.20
18
42
11
7
17.48
7.42
1.1
1.0
—
—
—
0
0
62
342
3.25
7.27
6.5
3.3
53.65
76.96
ug/l
1.37
62
321
11
8
15.29
7.08
1.1
1.3
—
—
—
0
0
11
8
15.29
7.08
1.1
1.3
—
—
—
0
0
11
8
15.29
7.08
1.1
1.3
—
—
—
0
0
11
8
15.29
7.08
1.1
1.3
—
—
—
0
0
11
8
15.29
7.08
1.1
1.3
—
—
—
0
0
17
45
4.37
6.12
1.7
1.6
—
—
—
0
0
80
547
3.64
5.95
31.9
11.6
3.25
3.76
e9/l
1.88
73
455
17
49
3.99
5.46
22.8
15.7
118.94
126.98
g/l
0.59
17
49
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
31
5.52
5.39
21.7
26.2
0.28
0.37
u/ml
—
10
23
44
228
2.70
5.35
30.8
10.4
1.19
1.30
mmol/l
0.14
35
164
11
15
8.11
5.31
1.1
1.2
—
—
—
0
0
13
23
6.35
5.28
2.4
10.7
40.90
543.93
g/mol
0.63
13
18
15
42
4.04
4.99
1.8
1.8
—
—
—
0
0
10
13
8.43
4.99
1.0
1.0
1.51
1.31
g/l
—
10
13
13
25
5.83
4.98
17.0
20.0
72.66
73.51
%
0.05
13
25
15
43
3.94
4.83
20.5
15.1
0.48
0.67
%
1.30
15
43
11
18
6.74
4.76
1.1
1.3
—
18.34
—
0
5
15
44
3.85
4.68
20.5
14.8
1.56
1.22
%
0.52
15
44
13
30
4.84
4.32
1.9
1.4
—
—
—
0
0
11
22
5.50
4.15
1.1
1.4
—
—
—
0
0
11
24
5.03
3.88
2.2
1.3
—
—
—
0
0
6
5
12.66
3.81
2.2
1.8
0.68
1.30
g/l
—
6
5
10
20
5.44
3.80
1.3
1.2
—
—
—
0
0
11
25
4.82
3.75
1.2
1.2
—
—
—
0
0
8
14
6.12
3.41
2.4
1.9
—
—
—
0
0
11
29
4.14
3.30
2.4
1.3
—
—
—
0
0
12
35
3.76
3.24
4.0
2.1
—
—
—
0
0
12
35
3.76
3.24
11.9
8.9
24.84
24.49
mmol/l
0.09
12
35
12
35
3.76
3.24
4.0
2.1
—
—
—
0
0
12
36
3.66
3.15
1.3
1.6
—
—
—
0
0
12
36
3.66
3.15
1.3
1.6
—
—
—
0
0
11
31
3.87
3.11
2.3
2.0
—
—
—
0
0
5
5
10.44
3.01
2.2
1.2
—
—
—
0
0
12
39
3.36
2.89
16.7
4.4
1.24
1.23
mmol/l
0.21
12
34
11
34
3.51
2.83
4.2
2.1
—
—
—
0
0
11
34
3.51
2.83
4.2
2.1
—
—
—
0
0
12
40
3.28
2.81
4.0
2.1
—
—
—
0
0
12
41
3.19
2.74
5.8
2.1
—
—
—
0
0
11
36
3.31
2.67
2.2
1.9
—
—
—
0
0
7
16
4.63
2.52
1.1
1.2
—
—
—
0
0
8
21
4.05
2.52
1.0
1.2
—
—
—
0
0
10
33
3.26
2.44
2.0
2.3
—
—
—
0
0
8
22
3.86
2.42
1.0
1.2
—
—
—
0
0
5
8
6.51
2.40
1.2
1.0
—
—
—
0
0
5
8
6.51
2.40
1.0
1.1
—
—
—
0
0
7
18
4.10
2.30
11.4
3.9
18.04
18.71
%
—
7
8
10
35
3.07
2.28
12.5
11.1
58.01
57.54
%
—
10
35
68
533
1.92
2.24
10.6
4.8
38.54
39.30
mmol/mol
0.20
68
503
90
796
2.81
2.19
76.6
18.6
14.21
13.90
%
0.79
90
790
6
14
4.49
2.18
4.8
2.6
53.67
51.79
%
—
6
14
6
14
4.49
2.18
1.7
1.3
90.50
104.36
%
—
6
14
5
10
5.20
2.09
1.0
1.4
183.40
304.90
pmol/l
—
5
10
6
15
4.19
2.07
1.8
1.1
—
—
—
0
0
8
27
3.13
1.98
2.0
3.5
134.00
40.22
u/ml
—
8
27
80
677
2.04
1.91
3.6
3.7
—
—
—
0
0
8
28
3.02
1.91
2.0
1.7
—
—
—
0
0
11
47
2.51
1.85
1.6
1.4
—
—
—
0
0
5
12
4.33
1.84
1.2
1.2
87.20
93.00
%
—
5
12
8
29
2.91
1.83
1.5
2.2
—
—
—
0
0
60
473
1.70
1.73
30.7
11.8
88.56
86.50
ml/min/173m2
0.19
47
353
10
46
2.31
1.45
1.0
1.8
—
—
—
0
0
6
25
2.49
1.26
1.2
4.6
3.45
3.51
mmol/l
—
6
25
8
40
2.09
1.15
1.0
1.2
—
—
—
0
0
13
76
1.82
1.05
1.6
1.3
—
—
—
0
0
32
239
1.51
1.03
6.5
3.8
—
—
—
0
0
6
27
2.30
0.95
1.2
5.0
241.17
400.63
mg/l
—
6
27
20
137
1.58
0.94
7.1
3.6
30.20
12.33
mg/mmol
0.39
15
85
9
54
1.73
0.77
3.7
4.4
—
—
—
0
0
27
207
1.42
0.75
2.3
1.9
94.90
96.13
pmol/l
0.04
13
103
5
28
1.83
0.67
1.2
3.7
21.00
24.18
%
—
5
28
5
29
1.76
0.64
1.2
3.6
8.00
7.79
%
—
5
29
5
30
1.70
0.62
1.4
3.5
—
—
—
0
0
0
23
0.00
0.59
0.0
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
13
98
1.38
0.40
3.1
2.6
2.51
2.46
mmol/l
0.92
13
85
0
19
0.00
0.39
0.0
1.0
—
81.37
—
0
19
7
53
1.35
0.31
1.7
2.5
8.60
5.42
ug/l
—
7
47
12
94
1.32
0.29
1.2
1.5
145.25
272.93
u/ml
0.47
12
88
5
72
0.68
0.27
1.0
1.0
3.12
3.43
kpa
—
5
55
5
73
0.67
0.27
1.0
1.0
7.24
7.43
kpa
—
5
56
5
38
1.33
0.23
3.2
4.0
0.00
0.14
e6/l
—
5
38
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
6
47
1.29
0.21
1.2
1.6
—
—
—
0
0
20
175
1.18
0.20
8.0
4.2
0.00
0.00
estimate
—
8
54
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
6
51
1.19
0.20
8.7
4.8
35.60
23.59
nmol/l
—
6
51
6
52
1.16
0.19
1.2
1.2
—
—
—
0
0
7
58
1.22
0.18
1.4
1.7
—
—
—
0
0
31
287
1.12
0.15
1.9
2.0
—
—
—
0
0
10
87
1.17
0.10
2.5
2.1
—
—
—
0
0
6
53
1.14
0.09
1.0
1.5
—
—
—
0
0
5
62
0.80
0.08
1.2
1.1
—
—
—
0
0
18
176
1.03
0.00
3.5
3.7
14.92
25.78
ng/l
1.48
12
118
10
99
1.01
0.00
1.1
1.1
—
—
—
0
0
8
80
1.00
0.00
2.6
2.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
9.76
—
0
5
0
5
0.00
-0.00
0.0
4.0
—
65.80
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
59
1.02
-0.00
8.7
8.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
0.60
—
0
5
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
57
0.87
-0.00
1.4
1.9
14.20
11.87
nmol/l
—
5
50
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
25.32
—
0
6
0
5
0.00
-0.00
0.0
6.6
—
197.14
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_BILI and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_BILI.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_BILI – Congenital malformation of biliary tract
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data